BNF 84 (British National Formulary) September 2022-March 2023: 84: September 2022 - March 2023

Product Information

Blood Results in Clinical Practice: A Practical Guide to Interpreting Blood Test Results - 2nd ed. (2019) Joint Formulary Committee (2021) 'Paracetamol', in British National Formulary. Available at: https://www-medicinescomplete-com.apollo.worc.ac.uk/#/content/bnf/_970446495(Accessed: 21July2022). For each vaccine monograph, the Drug action section includes a short summary of the vaccine type. Detailed information on the vaccine’s mechanism of action can be found in the corresponding Treatment summaries. The classifications, which are used to group similar vaccines, have also been updated.

Over the last year, we have undertaken research to understand how we could ensure that specialist drug content in BNF Publications is aligned with the stated scope within the preface, and with the primary use case of the BNF. Analytics around the use of BNF Publications’ content confirmed that specialist drug content is accessed much less frequently than drug content for non-specialist use. User research supported the analytics, and showed that those users who did access specialist content were most commonly looking at safety information, such as contra-indications, interactions, and side-effects.Vaccine monographs in the BNF and BNF for Children have been updated to more clearly identify whether a vaccine is live or not. With the latest update, you now have access to the new features on the BNF app, providing you with an improved experience. Ibrutinib (Imbruvica®): new risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events The cover image preview of BNF 84 (British National Formulary) September 2022 – March 2023 PDF Looks Something like this:

The vaccines class monograph has also been reviewed and updated. Information that is common to all vaccines can be found in the Vaccines, general class monograph. A new class monograph Vaccines, live contains information that is only relevant to live vaccines. Some monographs may have additional information that is specific to the individual vaccine. In such cases, information from the class monograph(s) and the individual monograph need to be considered together. As noted in the British National Formulary (BNF) the recommended dosage for children under 12 is...(Joint Formulary Committee, 2021)."An integral part of the UK’s healthcare infrastructure and relied on by health professionals who prescribe, dispense, and administer medicines globally. Containing guidance on best practice in prescribing, as well as legal and ethical considerations, BNF supports safe and effective decision-making at the point of care. Pre-treatment screening advice on genetic testing for aminoglycoside exposure posing risk to hearing

A British National Formulary (BNF) is a medical and pharmaceutical publication that contains information and advice on prescribing and pharmacology, along with specific facts and details about all medicines available on the NHS. Physicochemical Principles of Pharmacy in Manufacture, Formulation and Clinical Use - 6th ed. (2016) Adrenaline/epinephrine: recall of Emerade® 500 micrograms and Emerade® 300 micrograms auto-injectors, due to the potential for device failure [National Patient Safety Alert advice] Paper copies were historically distributed yearly, each October. The digital versions will take over from this October 2018. The results of this research have enabled us to critically review the information that should be included within specialist drug monographs. “Specialist drug” monographs will contain less detail than a regular monograph within BNF Publications, in a consistent format. A “specialist” monograph will continue to include information to support patient safety and non-specialist patient care (such as important safety information, interactions, side-effects, and contra-indications), but it will not contain information which is within the remit of specialist care (such as doses, and directions for administration). The current level of additional prescribing information has been retained for drug monographs that have a mix of specialist and non-specialist uses (such as methotrexate that is used for both malignancy and rheumatological conditions).Author (Year of publication) 'Title of chapter/section', in Title of reference source.Available at: URL (Accessed: date). Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017)